Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quesney, L. F.
Right arrow Articles by Prelevic, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quesney, L. F.
Right arrow Articles by Prelevic, S.
NEUROLOGY 1980;30:1169
© 1980 American Academy of Neurology

Transient abolition of generalized photosensitive epileptic discharge in humans by apomorphine, a dopamine-receptor agonist

L. F. Quesney, M.D., Ph.D., F. Andermann, M.D., S. Lal, M.D. and S. Prelevic, M.D.

Department of Neurology and Neurosurgery (Drs. Quesney, Andermann, Lal, and Prelevic), McGill University, Montreal Neurological Hospital (Drs. Quesney, Andermann, and Prelevic), and Montreal General Hospital (Dr. Lal), Canada.

Apomorphine, an agonist of dopamine receptors, blocks or significantly reduces photically induced seizures in the baboon (Papio papio). We therefore studied the effect of subcutaneously administered apomorphine in 11 patients with generalized photosensitive epilepsy. Visual evoked potentials were not altered by apomorphine, but in nine patients apomorphine transiently blocked the epileptic photosensitivity for an average of 45 minutes. Therefore, dopaminergic mechanisms play a role in the pathophysiology of human generalized photosensitive epilepsy.

Address correspondence and reprint requests to Dr. Quesney, Montreal Neurological Institute, 3801 University, Montreal, Quebec H3A 2B4, Canada.

Accepted for publication January 18, 1980.

Presented in part at the Epilepsy International Symposium, Vancouver, B.C., Canada, September 1978.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.